Post by Ross Muken

I'm thrilled to share that SOPHiA GENETICS has just announced our most significant partnership expansion to date with AstraZeneca—our largest deal in company history! This multi-year collaboration represents a transformative moment in our journey to democratize data-driven medicine. Together, we're harnessing the power of our multimodal AI Factories to revolutionize breast cancer treatment outcomes through: 🔍 Predictive insights from genomics, imaging, and clinical data 🧠 Bespoke AI-powered models for optimized patient outcomes 🌍 Real-world evidence initiatives spanning Europe and North America 📈 Enhanced clinical decision-making to drive treatment efficacy This groundbreaking partnership wouldn't have been possible without the incredible vision, dedication, and collaboration of our partners at AstraZeneca. I want to give a special shout-out to David Dellamonica, our key sponsor and alliance partner, whose leadership and support have been instrumental in making this historic deal a reality. I also want to extend my deepest gratitude to David Fredrickson, Susan Galbraith, Greg Rossi, Sunil Verma, Bob Li, Kristina Rodnikova, Thorsten Gutjahr, Jorge Reis-Filho, Sonny Shergill, Ashley Easter, John Longshore, Ph.D., FACMG, Michael Senior, Ryan Demers, and the many others who believed in our shared mission and made this partnership possible. This is more than a business milestone—it's a testament to what's possible when innovative organizations unite around improving patient lives. Together, we're not just advancing technology; we're bringing timely, personalized, data-driven care to patients who need it most. Thank you to everyone who has supported this incredible journey. The future of precision medicine is here! 🚀 #PrecisionMedicine #BreastCancer #AI #Partnership #Innovation #Grateful

Video Content